Daily Kimchi Consumption Tied to Lower Odds of Obesity
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 2, 2024 -- Daily consumption of kimchi may lower men's overall risk of obesity, according to a study published online Jan. 30 in BMJ Open.
Hyein Jung, from Chung Ang University in Anseong, South Korea, and colleagues assessed the association between kimchi consumption and obesity using data from 115,726 participants (aged 40 to 69 years) enrolled in the Health Examinees study in Korea.
The researchers found that in men, total kimchi consumption of one to three servings per day was related to a lower prevalence of obesity (odds ratios, 0.875 and 0.893 for one to two servings per day and for two to three servings per day, respectively) compared with less than one serving per day. Men with the highest consumption of cabbage kimchi had 10 percent lower odds of obesity and abdominal obesity. When compared with no consumption, median consumption or higher of radish kimchi was inversely associated with lower odds of abdominal obesity (8 percent for men and 11 percent for women).
"Since all results showed a 'J-shaped' association, it is recommended to limit excessive kimchi intake," the authors write.
Two authors disclosed being members of the staff at the World Institute of Kimchi.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Weight Navigation Program Boosts Use of Weight Management Treatments
FRIDAY, May 31, 2024 -- A primary care-based weight navigation program (WNP) is feasible and associated with greater use of weight management treatments (WMT) and weight loss...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.